Group One Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Sell |
16,778
-13,263
| -44% | -$230K | ﹤0.01% | 808 |
|
|
2025
Q1 | $657K | Buy |
+30,041
| New | +$657K | ﹤0.01% | 482 |
|
|
2024
Q4 | – | Sell |
-42,153
| Closed | -$1.22M | – | 2096 |
|
|
2024
Q3 | $1.22M | Buy |
42,153
+7,454
| +21% | +$215K | ﹤0.01% | 347 |
|
|
2024
Q2 | $1.33M | Buy |
+34,699
| New | +$1.33M | 0.01% | 293 |
|
|
2024
Q1 | – | Sell |
-253,905
| Closed | -$15.2M | – | 1817 |
|
|
2023
Q4 | $15.2M | Buy |
253,905
+27,221
| +12% | +$1.63M | 0.04% | 47 |
|
|
2023
Q3 | $8.62M | Buy |
226,684
+207,866
| +1,105% | +$7.91M | 0.03% | 69 |
|
|
2023
Q2 | $1.71M | Buy |
18,818
+13,908
| +283% | +$1.27M | 0.01% | 249 |
|
|
2023
Q1 | $324K | Sell |
4,910
-45,913
| -90% | -$3.03M | ﹤0.01% | 557 |
|
|
2022
Q4 | $2.63M | Buy |
+50,823
| New | +$2.63M | 0.01% | 202 |
|
|
2022
Q3 | – | Sell |
-25,823
| Closed | -$1.17M | – | 1996 |
|
|
2022
Q2 | $1.17M | Sell |
25,823
-29,723
| -54% | -$1.34M | ﹤0.01% | 409 |
|
|
2022
Q1 | $2.82M | Buy |
55,546
+19,525
| +54% | +$992K | ﹤0.01% | 308 |
|
|
2021
Q4 | $1.7M | Sell |
36,021
-69,731
| -66% | -$3.3M | ﹤0.01% | 525 |
|
|
2021
Q3 | $3.49M | Buy |
+105,752
| New | +$3.49M | ﹤0.01% | 312 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2019 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1867 |
|
|
2020
Q4 | – | Sell |
-1,629
| Closed | -$49K | – | 1676 |
|
|
2020
Q3 | $49K | Buy |
+1,629
| New | +$49K | ﹤0.01% | 1082 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1413 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1386 |
|
|
2019
Q4 | – | Sell |
-100
| Closed | -$2K | – | 1369 |
|
|
2019
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1209 |
|